CorMedix (CRMD) Profit After Tax (QoQ) (2010 - 2025)
CorMedix (CRMD) Profit After Tax (QoQ) (2010 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
CorMedix |
631,378.03 |
-154.57 Mn |
107.31 Mn |
| Date | Value |
|---|
| Sep 30, 2025 |
5,250.57% |
| Jun 30, 2025 |
-90.17% |
| Mar 31, 2025 |
53.32% |
| Dec 31, 2024 |
584.89% |
| Sep 30, 2024 |
80.38% |
| Jun 30, 2024 |
2.17% |
| Mar 31, 2024 |
1.95% |
| Dec 31, 2023 |
-51.41% |
| Sep 30, 2023 |
13.56% |
| Jun 30, 2023 |
-6.68% |
| Mar 31, 2023 |
-28.75% |
| Dec 31, 2022 |
-19.75% |
| Sep 30, 2022 |
9.88% |
| Jun 30, 2022 |
-8.11% |
| Mar 31, 2022 |
9.71% |
| Dec 31, 2021 |
9.08% |
| Sep 30, 2021 |
-84.97% |
| Jun 30, 2021 |
35.80% |
| Mar 31, 2021 |
-18.56% |
| Dec 31, 2020 |
7.78% |
